Rchr
J-GLOBAL ID:200901087579064168   Update date: Jul. 23, 2024

Yorinaka Hoichi

ヨリナカ ホウイチ | Yorinaka Hoichi
Affiliation and department:
Job title: Assistant Professor
Homepage URL  (1): http://www.geocities.jp/yorinakah
Research field  (1): Pharmacology
Research keywords  (2): 心血管薬理学 ,  Cardiovascular Pharmacology
Research theme for competitive and other funds  (5):
  • 2013 - 2017 抗TNNI3Kモノクローナル抗体を用いた虚血性心疾患の新型診断薬の開発
  • 2010 - 2013 心筋細胞収縮機能調節におけるTNNI3K とcTnIの相互作用
  • 2012 - TNNI3KのC末端調節領域の変異とマウス心筋不整脈発生率の上昇
  • 2012 - Mutation of Tnni3k gene increased incidence of cardiac arrhythmias
  • 2010 - MAPキナーゼTNNI3Kを用いた新しい心疾患診断薬の展開研究と開発
Papers (1):
MISC (69):
Patents (4):
  • MAPキナーゼTNNI3Kを用いた心疾患の治療剤
  • 一种血中TNNI3K的浓度的检测试剂盒及其制备方法和应用 (In Chinese)
  • 新規MAPキナーゼTNNI3Kを用いた心疾患の治療法
  • MAPキナーゼTNNI3Kを用いた心疾患治療剤(PCT) JP2005-021535
Books (9):
  • The effect of chloride on cultured rat ventricular myocytes during anoxia reoxygenation injury. (in Chinese)
    Chinese Pharmacol. Bulletin. 2005
  • Modulation of intracellular Ca2+ signalling during T cell activation and its significances (III) (in Chinese).
    Chinese J. Cardiovasc. Review. 2004
  • 日中学術交流20周年記念事業報告書
    2004
  • Modulation of intracellular Ca2+ signalling during T cell activation and its significances (I) (in Chinese).
    Chinese J. Cardiovasc. Review. 2004
  • Modulation of intracellular Ca2+ signalling during T cell activation and its significances (II) (in Chinese).
    Chinese J. Cardiovasc. Review. 2004
more...
Lectures and oral presentations  (70):
  • TNNI3K is a novel molecular target for treatment of cardiac diseases.
    (symposium 2015: The 89th Annual meeting of the Japanese Pharmacological society, 2016)
  • Functional analysis of TNNI3K MAP kinase - From basic to clinical research.
    (ASCEPT-BPS symposium 2015)
  • Circulating tnni3k levels are useful diagnosis biomarker for acute ischemic myocardial diseases.
    (ATVB|PVD symposium 2015 2015)
  • Pharmacological studies on controlled-release tablets of sasanquasaponin.
    (第7回トランスポーター研究会九州部会 2014)
  • Circulating level of cardiac-specific MAP kinase TNNI3K would be a useful diagnosis biomarker for acute ischemic myocardial diseases.
    (第8回次世代を担う若手医療薬科学シンポジウム 2014)
more...
Works (24):
  • 血中TNNI3Kレベルの変化に基づく急性虚血性心疾患の新しい診断法
    2013 - 2018
  • Editor Board Members of World Journal of Hypertension
    2011 - 2015
  • MAPキナーゼTNNI3Kを用いた新しい心疾患診断薬の展開研究と開発
    2011 - 2013
  • Editor Board Members of The Open Biomed Engineering Journal
    2010 - 2013
  • サザンカサポニン徐放剤のマウス心血管への薬理学的効果
    2011 - 2012
more...
Education (2):
  • - 1996 Others
  • - 1982 江西医学院 -
Professional career (3):
  • Medicine
  • Master of Medical Science
  • Doctor of Medicine
Work history (14):
  • 2010 - Kumamoto University Faculty of Life Sciences
  • 2010 - Assistant Professor,Faculty of Life Sciences(Basic medicine group),Kumamoto University
  • 2007 - 2009 助教
  • 2007 - 2009 Assistant Professor,
  • 2003 - 2007 助手
Show all
Committee career (23):
  • 2014 - 2017 2011 World Journal of Hypertension Editorial Board Members of World Journal of Cardiology(2014-2017)
  • 2013 - 2014 2011 World Journal of Hypertension 編集委員(2013-2014)
  • 2012 - Journal of Pharmaceutics & Pharmacology 編集委員 編集委員(2012)
  • 2012 - Editor Board Members of Journal of Pharmaceutics & Pharmacology Editoral Boad Member(2012)
  • 2010 - 2011 2007 日本トランスポーター研究会 幹事 幹事(2010-2011)
Show all
Awards (3):
  • 2012 - Fellow of American Heart Association
  • 1997 - 日本薬理雑誌最優秀論文賞1997(The JJp Prize in 1997)
  • 1991 - 中国衛生部科学技術進歩三等奨
Association Membership(s) (6):
日本心電学会 ,  日本循環器薬理学会 ,  中国生理学会 ,  日本和漢医薬学会 ,  ISHR (国際心臓学会) ,  ISHR
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page